Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Board Appointments

1 Jul 2013 07:00

RNS Number : 2131I
Oxford Catalysts Group PLC
01 July 2013
 



1st July 2013

 

OXFORD CATALYSTS GROUP PLC

("Oxford Catalysts" or "the Group" or "the Company")

 

Board Appointments

Oxford Catalysts Group PLC (OCG.L), the leading technology innovator for synthetic fuels production, is pleased to announce that Paul Schubert and Julian West have been appointed to the Board as Executive Director and Non-executive Director respectively, with immediate effect.

 

Paul Schubert has been the Group's Chief Operating Officer since 2011. He brings some thirty years of experience in the petrochemical and natural gas industries, having held various technical and general management roles with SGS Group, Syntroleum Corporation, Catalytica, Phillips Petroleum, and Engelhard Corporation. In these positions he was responsible for day-to-day operations, process development and commercialisation, plant design, and asset integrity management. Dr Schubert is the inventor or co-inventor of 16 US Patents and author of over 40 publications. He holds a PhD in Inorganic Chemistry from the University of Illinois, and a BS in Chemistry from the University of Arkansas.

 

Julian West brings forty years' experience of energy policy, in both the private and public sectors, and has broad expertise in international politics, privatisation, energy economics, and regulation of energy companies. Until 2008, he was a Senior Director at Cambridge Energy Research Associates (CERA), leading the firm's oil teams. Before joining CERA in 1996, Mr West was an executive and main Board Director at Enterprise Oil plc, where he was responsible for the company's planning and business development. Previously, at the UK Department of Energy (1974-83), he focused on oil and energy policy and financial control and, under different administrations, served as Principal Private Secretary to a Minister of State and three Secretaries of State.

 

Commenting on his appointment, Paul Schubert said:

 

"I am glad to join the board of Oxford Catalysts. Over the last few years the Company has grown from a developer of innovative technology for synthetic fuels production into a business capable of fully deploying the commercial embodiment of that technology to meet current market needs. I am looking forward to being able to contribute to the growth and success of the Company at a new level."

 

Commenting on his appointment, Julian West said:

 

"I've worked with Oxford Catalysts as a consultant since 2009. The Group has been stimulating and challenging as a client, so I am looking forward to this new relationship. It is a company for whose people and prospects I have acquired high regard."

 

Commenting on the appointments, Pierre Jungels, Chairman of Oxford Catalysts, said:

 

"I am pleased Julian West and Paul Schubert have agreed to join our Board at this critical phase of our development. Through his experience in senior commercial roles and as a consultant for the highly regarded CERA organisation, Julian brings us a deep knowledge of oil and gas markets worldwide and contacts at the highest level of the industry, both publicly and state owned. He has helped us already in the past few years and his understanding of our business and the needs of our potential clients will inform our Board in a very positive way.

 

"With our Company nearing possible explosive growth, a significant part of our success will depend on technical and operational excellence. Paul Schubert, as Chief Operating Officer, will add to the strength of the team of Executive Directors at this important juncture for the Company's progress."

 

The directorships and partnerships held by Dr Schubert (full name: Paul Frederick Schubert) (aged 57) now and over the five years preceding the date of appointment are as follows:

 

Current Directorships / Partnerships

None

 

Directorships in the past 5 years

None

The directorships and partnerships held by Mr West (full name: Julian Daniel West) (aged 62) now and over the five years preceding the date of appointment are as follows:

 

Current Directorships / Partnerships

Executive Director/Partner: Julian West Consultancy Limited

 

Directorships in the past 5 years

None

As at the date of this announcement, Dr Schubert has an interest in 1,120,775 share options in the capital of the Company and Mr West has an interest in 75,000 ordinary shares in the share capital of the Company (which are in turn held through Julian West Consultancy Limited, which is owned 50 percent by Mr West and 50 percent by his wife).

 

There are no other matters to be announced as required under paragraph (g) of Schedule 2 of the AIM Rules.

 

- Ends -

 

 

For further information, please contact:

 

Oxford Catalysts

Roy Lipski, CEO

Susan Robertson, CFO

 

+44 (0)1235 841 700

+1 614 733 3300

Lionsgate Communications

Jonathan Charles / Jessica Johnson

 

+44 (0)7791 892509

 

Cenkos Securities (Nomad and Joint Broker)

Ken Fleming / Neil McDonald

 

+44 (0)20 7397 8900

+44 (0)131 220 9772

Numis Securities (Joint Broker)

Alex Ham

+44 (0)20 7260 1000

 

Notes to Editors

 

Oxford Catalysts enables Gas-to-Liquids (GTL) plants to convert unconventional, remote and problem gas into valuable liquid fuels. Systems based on the Group's technology (marketed under the brand name Velocys) are significantly smaller than those using conventional technology, enabling modular plants that can be deployed cost effectively in remote locations and on smaller fields than is possible with competing systems. Together with world-class partners, Oxford Catalysts provides complete smaller scale modular GTL solutions that address an untapped market of up to 25 million barrels of fuel a day.

 

Oxford Catalysts Group PLC is listed on the AIM market of the London Stock Exchange (LSE: OCG). The Group has some 90 employees with facilities near Oxford, UK and Columbus, Ohio, USA.

 

www.oxfordcatalysts.com

www.velocys.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUMPQUPWGBR
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.